Latest Heartware International (HTWR) Headlines
Post# of 24
Posted On: 03/13/2014 9:35:16 AM
Latest Heartware International (HTWR) Headlines
HeartWare Presentation At The 2014 Barclays Global Healthcare Conference To Be Webcast
PR Newswire - Fri Mar 07, 8:00AM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Barclays Global Healthcare Conference at 10:15 a.m. EDT on Tuesday, March 11, 2014. The conference is being held March 11-13 at Loews Miami Hotel.
Thoratec Warns About HeartMate Controller - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:00PM CST
Investors reacted negatively to the news, resulting in a 2.7% fall in THOR shares to $36.22 after the market closed yesterday
HeartWare Sees Narrower Loss but Misses Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 8:55AM CST
For full year 2013, HeartWare's loss was also narrower at $52.0 million or $3.24 per share compared with $86.6 million or $6.07 per share in 2012.
HeartWare International Reports Fourth Quarter 2013 Results
PR Newswire - Thu Feb 27, 6:00AM CST
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $53.1 million for the fourth quarter ended December 31, 2013, a 62% increase compared to $32.7 million in revenue for the same period of 2012. For the fiscal year 2013, the company generated revenue of $207.9 million, an 87% increase compared to revenue of $110.9 million in fiscal year 2012.
HeartWare Presentation At The Raymond James 35th Annual Institutional Investors Conference To Be Webcast
PR Newswire - Wed Feb 26, 3:00PM CST
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Raymond James 35th Annual Institutional Investors Conference at 4:35 p.m. EST on Tuesday, March 4, 2014. The conference is being held March 2-5 at JW Marriott Grande Lakes, Orlando, Florida.
Insider Trading Alert - HTWR, IDTI And RFMD Traded By Insiders
at The Street - Tue Feb 18, 9:30AM CST
Stocks with insider trader activity include HTWR, IDTI and RFMD
HeartWare Schedules Fourth Quarter Conference Call And Webcast
PR Newswire - Tue Feb 04, 4:21PM CST
HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended December 31, 2013, at 8:00 a.m. U.S. Eastern Standard Time on Thursday, February 27, 2014. The Company plans to release the financial results prior to the conference call.
HeartWare Presentation At The 2014 Leerink Global Healthcare Conference To Be Webcast
PR Newswire - Tue Feb 04, 2:00PM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Leerink Global Healthcare Conference at 8:55 a.m. EST on Thursday, February 13, 2014. The conference is being held February 12-13 at the Waldorf Astoria in New York City.
29.9% Return Seen to Date on SmarTrend HeartWare International Call (HTWR)
Comtex SmarTrend(R) - Wed Jan 29, 9:48AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 29.87% as of today's recent price of $99.90.
Uptrend Call Working As HeartWare International Stock Rises 34.9% (HTWR)
Comtex SmarTrend(R) - Wed Jan 22, 9:20AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 34.86% as of today's recent price of $103.74.
HEARTWARE
at Investor's Business Daily - Tue Jan 14, 5:46PM CST
HEARTWARE (HTWR), an implantable heart-pump maker, said preliminary Q4 sales were $53 mil, up 62%, but below views for $58.4 mil. Shares dropped 9.9% to 93.
HeartWare gives weak revenue guidance
AP - Tue Jan 14, 5:07PM CST
FRAMINGHAM, Mass. (AP) — HeartWare International Inc. shares sank in after-hours trading Tuesday after the medical device company said that its revenue may fall short of market forecasts.
Shares of HTWR Up 34.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 14, 5:01PM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 34.22% as of today's recent price of $103.25.
HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues
PR Newswire - Tue Jan 14, 3:45PM CST
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it expects revenues for the fourth quarter of 2013 will be approximately $53 million, bringing expected full-year 2013 revenues to approximately $208 million.
Abiomed, Inc.: The Best Medical Device Companies of 2013
Todd Campbell, The Motley Fool - Motley Fool - Thu Jan 09, 12:54PM CST
With the S&P Healthcare Equipment Select Industry Index up 32% this past year, it's clear that the industry performed well in 2013 -- but which stocks were the biggest winners? Some of the best performers outpaced the index significantly last...
Insider Trading Alert - PLCE, HTWR, MMM, P And IBKR Traded By Insiders
at The Street - Wed Jan 08, 10:01AM CST
Stocks with insider trader activity include PLCE, HTWR, MMM, P and IBKR
HeartWare International Has Returned 30.0% Since SmarTrend Recommendation (HTWR)
Comtex SmarTrend(R) - Tue Jan 07, 11:10AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 30.00% as of today's recent price of $100.00.
MedTech Industry Stock Update - Jan 2014 - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 4:04AM CST
MedTech Industry Stock Update - Jan 2014 - Industry Outlook
MedTech Industry Stock Update - Jan 2014 - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 4:04AM CST
MedTech Industry Stock Update - Jan 2014 - Zacks Analyst Interviews
HeartWare International Up 20.8% Since SmarTrend Uptrend Call (HTWR)
Comtex SmarTrend(R) - Tue Dec 31, 9:31AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 2 months, HeartWare International has returned 20.75% as of today's recent price of $92.89.
HeartWare Presentation At The 2014 Barclays Global Healthcare Conference To Be Webcast
PR Newswire - Fri Mar 07, 8:00AM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Barclays Global Healthcare Conference at 10:15 a.m. EDT on Tuesday, March 11, 2014. The conference is being held March 11-13 at Loews Miami Hotel.
Thoratec Warns About HeartMate Controller - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 2:00PM CST
Investors reacted negatively to the news, resulting in a 2.7% fall in THOR shares to $36.22 after the market closed yesterday
HeartWare Sees Narrower Loss but Misses Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 03, 8:55AM CST
For full year 2013, HeartWare's loss was also narrower at $52.0 million or $3.24 per share compared with $86.6 million or $6.07 per share in 2012.
HeartWare International Reports Fourth Quarter 2013 Results
PR Newswire - Thu Feb 27, 6:00AM CST
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $53.1 million for the fourth quarter ended December 31, 2013, a 62% increase compared to $32.7 million in revenue for the same period of 2012. For the fiscal year 2013, the company generated revenue of $207.9 million, an 87% increase compared to revenue of $110.9 million in fiscal year 2012.
HeartWare Presentation At The Raymond James 35th Annual Institutional Investors Conference To Be Webcast
PR Newswire - Wed Feb 26, 3:00PM CST
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Raymond James 35th Annual Institutional Investors Conference at 4:35 p.m. EST on Tuesday, March 4, 2014. The conference is being held March 2-5 at JW Marriott Grande Lakes, Orlando, Florida.
Insider Trading Alert - HTWR, IDTI And RFMD Traded By Insiders
at The Street - Tue Feb 18, 9:30AM CST
Stocks with insider trader activity include HTWR, IDTI and RFMD
HeartWare Schedules Fourth Quarter Conference Call And Webcast
PR Newswire - Tue Feb 04, 4:21PM CST
HeartWare International, Inc. (NASDAQ:HTWR) has scheduled a conference call to discuss its financial results for the three months ended December 31, 2013, at 8:00 a.m. U.S. Eastern Standard Time on Thursday, February 27, 2014. The Company plans to release the financial results prior to the conference call.
HeartWare Presentation At The 2014 Leerink Global Healthcare Conference To Be Webcast
PR Newswire - Tue Feb 04, 2:00PM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Leerink Global Healthcare Conference at 8:55 a.m. EST on Thursday, February 13, 2014. The conference is being held February 12-13 at the Waldorf Astoria in New York City.
29.9% Return Seen to Date on SmarTrend HeartWare International Call (HTWR)
Comtex SmarTrend(R) - Wed Jan 29, 9:48AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 29.87% as of today's recent price of $99.90.
Uptrend Call Working As HeartWare International Stock Rises 34.9% (HTWR)
Comtex SmarTrend(R) - Wed Jan 22, 9:20AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 34.86% as of today's recent price of $103.74.
HEARTWARE
at Investor's Business Daily - Tue Jan 14, 5:46PM CST
HEARTWARE (HTWR), an implantable heart-pump maker, said preliminary Q4 sales were $53 mil, up 62%, but below views for $58.4 mil. Shares dropped 9.9% to 93.
HeartWare gives weak revenue guidance
AP - Tue Jan 14, 5:07PM CST
FRAMINGHAM, Mass. (AP) — HeartWare International Inc. shares sank in after-hours trading Tuesday after the medical device company said that its revenue may fall short of market forecasts.
Shares of HTWR Up 34.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Jan 14, 5:01PM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 34.22% as of today's recent price of $103.25.
HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues
PR Newswire - Tue Jan 14, 3:45PM CST
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it expects revenues for the fourth quarter of 2013 will be approximately $53 million, bringing expected full-year 2013 revenues to approximately $208 million.
Abiomed, Inc.: The Best Medical Device Companies of 2013
Todd Campbell, The Motley Fool - Motley Fool - Thu Jan 09, 12:54PM CST
With the S&P Healthcare Equipment Select Industry Index up 32% this past year, it's clear that the industry performed well in 2013 -- but which stocks were the biggest winners? Some of the best performers outpaced the index significantly last...
Insider Trading Alert - PLCE, HTWR, MMM, P And IBKR Traded By Insiders
at The Street - Wed Jan 08, 10:01AM CST
Stocks with insider trader activity include PLCE, HTWR, MMM, P and IBKR
HeartWare International Has Returned 30.0% Since SmarTrend Recommendation (HTWR)
Comtex SmarTrend(R) - Tue Jan 07, 11:10AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 3 months, HeartWare International has returned 30.00% as of today's recent price of $100.00.
MedTech Industry Stock Update - Jan 2014 - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 4:04AM CST
MedTech Industry Stock Update - Jan 2014 - Industry Outlook
MedTech Industry Stock Update - Jan 2014 - Zacks Analyst Interviews
Zacks Equity Research - Zacks Investment Research - Tue Jan 07, 4:04AM CST
MedTech Industry Stock Update - Jan 2014 - Zacks Analyst Interviews
HeartWare International Up 20.8% Since SmarTrend Uptrend Call (HTWR)
Comtex SmarTrend(R) - Tue Dec 31, 9:31AM CST
SmarTrend identified an Uptrend for HeartWare International (NASDAQ:HTWR) on October 24th, 2013 at $76.93. In approximately 2 months, HeartWare International has returned 20.75% as of today's recent price of $92.89.
(0)
(0)HeartWare International (HTWR) Stock Research Links
Scroll down for more posts ▼